These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2035219)

  • 1. Pharmacodynamics and pharmacokinetics of flunixin in the cat: a preliminary study.
    Taylor PM; Lees P; Reynoldson J; Stodulski G; Jefferies R
    Vet Rec; 1991 Mar; 128(11):258. PubMed ID: 2035219
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamics and pharmacokinetics of flunixin in the cat.
    Lees P; Taylor PM
    Br Vet J; 1991; 147(4):298-305. PubMed ID: 1913126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunixin in the cat: a pharmacodynamic, pharmacokinetic and toxicological study.
    Taylor PM; Winnard JG; Jefferies R; Lees P
    Br Vet J; 1994; 150(3):253-62. PubMed ID: 8044665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
    Lees P; Ewins CP; Taylor JB; Sedgwick AD
    Br Vet J; 1987; 143(5):462-76. PubMed ID: 3119142
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of and serum thromboxane suppression by flunixin meglumine in healthy foals during the first month of life.
    Semrad SD; Sams RA; Ashcraft SM
    Am J Vet Res; 1993 Dec; 54(12):2083-7. PubMed ID: 8116942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses.
    Semrad SD; Hardee GE; Hardee MM; Moore JN
    Am J Vet Res; 1985 Dec; 46(12):2474-9. PubMed ID: 4083579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and effects on thromboxane B2 production following intravenous administration of flunixin meglumine to exercised thoroughbred horses.
    Knych HK; Arthur RM; McKemie DS; Chapman N
    J Vet Pharmacol Ther; 2015 Aug; 38(4):313-20. PubMed ID: 25582761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of flunixin in the horse: its relationship to thromboxane B2 production.
    Soma LR; Uboh CE; Rudy J; Fegely J
    J Vet Pharmacol Ther; 1992 Sep; 15(3):292-300. PubMed ID: 1433493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flunixin pharmacokinetics and serum thromboxane inhibition in the dog.
    McKellar QA; Galbraith EA; Bogan JA; Russell CS; Hooke RE; Lees P
    Vet Rec; 1989 Jun; 124(25):651-4. PubMed ID: 2763429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats.
    Königsson K; Törneke K; Engeland IV; Odensvik K; Kindahl H
    Acta Vet Scand; 2003; 44(3-4):153-9. PubMed ID: 15074628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of flunixin meglumine in swine after intravenous dosing.
    Buur JL; Baynes RE; Smith G; Riviere JE
    J Vet Pharmacol Ther; 2006 Oct; 29(5):437-40. PubMed ID: 16958790
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood.
    Galbraith EA; McKellar QA
    Res Vet Sci; 1996 Jul; 61(1):78-81. PubMed ID: 8819199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of flunixin in chickens after oral and intravenous administration.
    Musser JM
    J Vet Pharmacol Ther; 2010 Jun; 33(3):312-4. PubMed ID: 20557449
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test.
    Colahan PT; Bailey JE; Chou CC; Johnson M; Rice BL; Jones GL; Cheeks JP
    Vet Ther; 2002; 3(1):37-48. PubMed ID: 12050827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of transdermal flunixin meglumine in Holstein calves.
    Kleinhenz MD; Van Engen NK; Gorden PJ; KuKanich B; Rajewski SM; Walsh P; Coetzee JF
    J Vet Pharmacol Ther; 2016 Dec; 39(6):612-615. PubMed ID: 27121728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on the pharmacokinetics and pharmacodynamics of flunixin meglumine following intravenous and transdermal administration to Holstein calves.
    Kleinhenz MD; Van Engen NK; Gorden PJ; Smith JS; KuKanich B; Rajewski SM; Walsh P; Perkins S; Coetzee JF
    Am J Vet Res; 2018 May; 79(5):568-575. PubMed ID: 29688783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of intravenous and transdermal flunixin meglumine in meat goats.
    Reppert EJ; Kleinhenz MD; Montgomery SR; Bornheim HN; Magnin G; Sidhu PK; Zhang Y; Joo H; Coetzee JF
    J Vet Pharmacol Ther; 2019 May; 42(3):309-317. PubMed ID: 30802981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of flunixin meglumine in the cow.
    Hardee GE; Smith JA; Harris SJ
    Res Vet Sci; 1985 Jul; 39(1):110-2. PubMed ID: 4035085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
    Semrad SD; Sams RA; Harris ON; Ashcraft SM
    Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of flunixin meglumine in dogs.
    Hardie EM; Hardee GE; Rawlings CA
    Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.